Can we predict superbug evolution in the ICU?

NCT ID NCT07744321

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study follows intensive care unit (ICU) patients over at least 28 days to see how two types of bacteria—Klebsiella pneumoniae and Enterobacter cloacae—change and evolve in their gut. By analyzing weekly stool samples, researchers hope to understand how these bacteria become more dangerous or resistant to drugs over time. The goal is to gather knowledge that could help hospitals better detect and prevent infections in critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could improve how hospitals detect and track dangerous, drug-resistant bacteria in intensive care patients, potentially leading to better infection control strategies.
What could go wrong
This is a small, observational study with only 20 participants, so findings may not apply broadly. It does not test a treatment, so it won't directly change patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENTEROBACTER CLOACAE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Caen University Hospital

    RECRUITING

    Caen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.